Project Grant K23HL183818
Award Date 4/10/26
Completion Date 3/31/31
Dollars Obligated $187K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Cincinnati, OH 45221, USA
Similar Awards
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Washington University a $195,846 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) effective August 1, 2025, with completion targeted for April 30, 2030. This K23 mentored career development award funds a prospective cohort study investigating the role of blood-brain barrier (BBB) disruption in ischemic brain injury and cognitive impairment among patients with sickle cell...
- Federal Grant Award Summary Vanderbilt University Medical Center received a $232,836 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective December 1, 2025 through November 30, 2027. This award supports quantitative neuroimaging research to develop biomarkers of ischemic risk in adults with sickle cell disease (SCD). The research employs non-invasive advanced imaging methods, including arterial spin...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Illinois a $755,853 Project Grant effective September 15, 2025, through June 30, 2030, under the Cardiovascular Diseases Research program (CFDA 93.837). This award funds research investigating sodium-glucose cotransporter-2 inhibitors (SGLT2i) as a therapeutic intervention for sickle cell disease (SCD)-related chronic kidney disease (CKD). The research will leverage preliminary data...
- Federal Project Grant Award Summary Drexel University received a $503,870 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025, through June 30, 2029. The award supports fundamental research on anti-sickling therapies for sickle cell disease, which affects approximately 100,000 Americans. The project addresses critical knowledge gaps in understanding how fetal hemoglobin...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Ohio State University a $765,931 Project Grant (CFDA 93.837: Cardiovascular Diseases Research) effective August 22, 2025, through July 31, 2030, to conduct a multi-center hybrid effectiveness-implementation trial evaluating patient-facing, evidence-based guidelines for sickle cell disease (SCD) management delivered through a mobile health (mHealth) application plus printed booklets. The primary...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Pennsylvania a $769,994 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate the impact of left ventricular assist device (LVAD) implantation on cerebral hemodynamics and cognitive function. The research project, which commenced on September 5, 2025, and is scheduled for completion by July 31, 2029, will utilize transcranial Doppler...
- Federal Grant Award Summary St. Jude Children's Research Hospital Inc. received a $277,500 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded August 1, 2025, with a completion date of July 31, 2027. The project addresses executive functioning impairment in pediatric patients with sickle cell disease (SCD) through a clinical investigation of methylphenidate (MPH) efficacy and safety. Sickle cell...
- Federal Project Grant Summary The University of Cincinnati's Sponsored Research Services Division received a $654,628 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective March 6, 2026, through February 28, 2031. This research initiative investigates the relationship between peripheral blood proteomics and cognitive decline following...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of North Carolina at Chapel Hill a Project Grant totaling $761,028 under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a multi-site prospective study examining sleep-associated hypoxemia in adults with sickle cell anemia (SCA). The four-year study, active from September 15, 2025 through June 30, 2029, investigates the prevalence, clinical impact, and therapeutic...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Johns Hopkins University a Project Grant totaling $1,352,049 on May 15, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate the role of microglial glutaminase in HIV-induced sleep deficits. The research addresses a significant health burden affecting 50–70% of virologically suppressed people with HIV (VSPWH), who experience insomnia rates 2.5 times higher than the...